Anat Loewenstein

OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant

Dinah Zur, Matías Iglicki, Catharina Busch et al. · Ophthalmology · 2017 · 264 citations

Health Professions, Ophthalmology, Optometry +17

Translocation of the Retina for Management of Subfoveal Choroidal Neovascularization II: A Preliminary Report in Humans

Eugene de Juan, Anat Loewenstein, Neil M. Bressler et al. · American Journal of Ophthalmology · 1998 · 235 citations · Full text

Medicine, Ophthalmology, Vision Science +13

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES

Matías Iglicki, Catharina Busch, Dinah Zur et al. · Retina · 2018 · 160 citations

Medicine, Ophthalmology, Surgery +15

Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema

Catharina Busch, Dinah Zur, Samantha Fraser‐Bell et al. · Acta Diabetologica · 2018 · 136 citations

Medicine, Ophthalmology, Pharmacotherapy +10

Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant

Dinah Zur, Matías Iglicki, Anna Sala‐Puigdollers et al. · Acta Ophthalmologica · 2019 · 126 citations · Full text

Health Professions, Ophthalmology, Vision Science +17